BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11169731)

  • 1. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells.
    Wang X; Studzinski GP
    J Cell Biochem; 2001; 80(4):471-82. PubMed ID: 11169731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
    Wang QM; Jones JB; Studzinski GP
    Cancer Res; 1996 Jan; 56(2):264-7. PubMed ID: 8542578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid.
    Drayson MT; Michell RH; Durham J; Brown G
    Exp Cell Res; 2001 May; 266(1):126-34. PubMed ID: 11339831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HL60 cells halted in G1 or S phase differentiate normally.
    Brown G; Drayson MT; Durham J; Toellner KM; Hughes PJ; Choudhry MA; Taylor DR; Bird R; Michell RH
    Exp Cell Res; 2002 Nov; 281(1):28-38. PubMed ID: 12441127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants.
    Studzinski GP; Rathod B; Wang QM; Rao J; Zhang F
    Exp Cell Res; 1997 May; 232(2):376-87. PubMed ID: 9168815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
    Danilenko M; Wang X; Studzinski GP
    J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 5 activity enhances monocytic phenotype and cell cycle traverse in 1,25-dihydroxyvitamin D3-treated HL60 cells.
    Chen F; Studzinski GP
    Exp Cell Res; 1999 Jun; 249(2):422-8. PubMed ID: 10366442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3.
    Wang Q; Wang X; Studzinski GP
    J Cell Biochem; 2003 Aug; 89(6):1087-101. PubMed ID: 12898508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
    Yen A; Roberson MS; Varvayanis S; Lee AT
    Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells.
    Marcinkowska E
    Anticancer Res; 2001; 21(1A):499-504. PubMed ID: 11299787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is.
    Yen A; Varvayanis S
    In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta.
    Deszo EL; Brake DK; Cengel KA; Kelley KW; Freund GG
    J Biol Chem; 2001 Mar; 276(13):10212-7. PubMed ID: 11124968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
    Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
    Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D(3)-induced differentiation of human leukemia HL60 cells.
    Wang X; Rao J; Studzinski GP
    Exp Cell Res; 2000 Aug; 258(2):425-37. PubMed ID: 10896794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering of p27Kip1 levels by its antisense or by development of resistance to 1,25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells.
    Wang QM; Chen F; Luo X; Moore DC; Flanagan M; Studzinski GP
    Leukemia; 1998 Aug; 12(8):1256-65. PubMed ID: 9697881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor.
    Gaté L; Lunk A; Tew KD
    Biochem Pharmacol; 2003 May; 65(10):1611-22. PubMed ID: 12754097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p21WAF1 is dependent on the activation of ERK during vitamin E-succinate-induced monocytic differentiation.
    Lee JK; Jung JC; Chun JS; Kang SS; Bang OS
    Mol Cells; 2002 Feb; 13(1):125-9. PubMed ID: 11911463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation.
    Chen F; Wang Q; Wang X; Studzinski GP
    Cancer Res; 2004 Aug; 64(15):5425-33. PubMed ID: 15289351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betulinic acid enhances 1alpha,25-dihydroxyvitamin D3-induced differentiation in human HL-60 promyelocytic leukemia cells.
    Poon KH; Zhang J; Wang C; Tse AK; Wan CK; Fong WF
    Anticancer Drugs; 2004 Jul; 15(6):619-24. PubMed ID: 15205607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.